TBPH

Theravance Biopharma (TBPH)

About Theravance Biopharma (TBPH)

Theravance Biopharma, Inc. is a biopharmaceutical company, which engages in the discovery, research, development, and commercialization of respiratory medicines. It operates through the following geographical segments: U.S. and Europe. The company was founded in July 2013 and is headquartered in South San Francisco, CA.

Details

Daily high

$16.80

Daily low

$16.43

Price at open

$16.79

52 Week High

$21.03

52 Week Low

$9.04

Market cap

851.1M

Dividend yield

0.00%

Volume

386,644

Avg. volume

336,732

P/E ratio

7.49

Theravance Biopharma News